Abstract
Two new compounds based on Cd(II) ion as metal nodes, that is, [Cd (pam) (3-bpmh) (DMF)] n ( 1 ) and [Cd 2 (Hbci) 2 (3-bpmh) 2 ] n ·nH 2 O ( 2 ) (3-bpmh is N, N -bis-pyridin-3-ylmethylene-hydrazine, H 3 bci = bis(2-carboxyethyl)isocyanurate, and H 2 pam = pamoic acid), were successfully prepared via a dual-ligand strategy under solvothermal conditions. Furthermore, the luminescent performances and thermal stabilities of the prepared compounds were explored. During myocardial infarction, there were characteristic changes of the patients' electrocardiograms. For the treatment of ischemic myocardial infarction, the adenosine 5′-monophosphate-activated protein kinase inflammatory signaling pathway was determined through applying real-time reverse transcription-polymerase chain reaction after conducting the indicated treatment. Next, the enzyme-linked immunosorbent assay was implemented, and the levels of inflammatory cytokines during ischemic myocardial infarction were determined. • Two Cd(II) compounds were successfully prepared. • Their luminescent performances and thermal stabilities were explored. • Their treatment activity on ischemic myocardial infarction was evaluated via real time RT-PCR.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
